Orphan Cancer Drugs in the Era of Precision Medicine

Main|Search|PHGKB




Last Posted: Aug 23, 2018

---

• Orphan Cancer Drugs in the Era of Precision Medicine
  C Nabhan et al, JAMA Oncology, August 23, 2018
• A precision medicine approach to pharmacological adjuncts to extinction: a call to broaden research.
  King Gabrielle et al. Psychopharmacology 2018 Aug
• Advancing precision medicine with personalized drug screening.
  Gorshkov Kirill et al. Drug discovery today 2018 Aug
• Cancer precision medicine today: Towards omic information in healthcare systems.
  Maggi Norbert et al. Tumori 2018 Aug 300891618792473
• FH 2018 Global Summit, October 1-2, 2018
  The FH Foundation, 2018
• Genomic medicine must reduce, not compound, health inequities: the case for hauora-enhancing genomic resources for New Zealand.
  Robertson Stephen P et al. The New Zealand medical journal 2018 Aug 131(1480) 81-89
• Precision medicine and sharing medical data in real time: opportunities and barriers.
  Yang Y Tony et al. The American journal of managed care 2018 Aug 24(8) 356-358
• Rise of Deep Learning for Genomic, Proteomic, and Metabolomic Data Integration in Precision Medicine.
  Grapov Dmitry et al. Omics : a journal of integrative biology 2018 Aug
• Targeted molecular analysis in adrenocortical carcinomas: a strategy towards improved personalized prognostication.
  Lippert Juliane et al. The Journal of clinical endocrinology and metabolism 2018 Aug
• Redefining the Value Proposition of Precision Oncology- Can We Integrate Genomic Testing Without Overselling It? 
  HJ West, JAMA Oncology, August 2018

more